During the last three years Denmark-based VANOVI, the holding company of AGITO Medical, has bought, sold, and merged with the interest of streamlining and focusing its business around diagnostic imaging equipment.

Recently, VANOVI succeeded in selling Lindeq A/S, a pharmacovigilance company — and one of its last remaining non-diagnostic imaging assets — to Pharmalex. The sale is expected to enable greater investment from VANOVI into the core business areas of AGITO Medical, while also allowing Lindeq access to the resources it needs to grow.

"We are extremely satisfied with the sale and the positive influence it will have on shaping the future of AGITO medical," Anders Fage Jensen, CEO of AGITO Medical, told HCB News. "This fits very well with our strategy of optimizing, consolidating, and controlled growth within our core business."
VANOVI shareholders reinvested €2 million from the Lindeq transaction into AGITO Medical, an investment intended to strengthen the operation of the company while further financing its growth.

In addition to the core areas — including the sale of used imaging equipment, rental of CT and MR trailers and modular buildings, imaging spare parts sales and service contracts — some of this investment has gone toward a brand new repair facility including an MR RF cabin and test bays for CT and general imaging equipment.

"We wish to keep improving our products and the new facility will help us improve both quality and speed in the spare parts and equipment handling," said an AGITO spokesperson. "Additionally, we are now able to offer technical service training to service engineers at our facility, where we will be launching the first courses later this year."

Business Affairs Homepage